101 related articles for article (PubMed ID: 33651452)
61. Sweet but sour: Impaired attention functioning in children with type 1 diabetes mellitus.
Lancrei HM; Yeshayahu Y; Grossman ES; Berger I
Front Hum Neurosci; 2022; 16():895835. PubMed ID: 36158626
[TBL] [Abstract][Full Text] [Related]
62. The relationship between diabetes mellitus and attention deficit hyperactivity disorder: A systematic review and meta-analysis.
Ai Y; Zhao J; Liu H; Li J; Zhu T
Front Pediatr; 2022; 10():936813. PubMed ID: 36245747
[TBL] [Abstract][Full Text] [Related]
63. An analysis of cognitive functioning of children and youth with type 1 diabetes (T1DM) in the context of glycemic control.
Stanisławska-Kubiak M; Mojs E; Wójciak RW; Piasecki B; Matecka M; Sokalski J; Kopczyński P; Fichna P
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3453-3460. PubMed ID: 29917198
[TBL] [Abstract][Full Text] [Related]
64. The contribution of art therapy in poorly controlled youth with type 1 diabetes mellitus.
Harel S; Yanai L; Brooks R; Bar Y; Bistritzer T; Ivgi S; Rachmiel M
J Pediatr Endocrinol Metab; 2013; 26(7-8):669-73. PubMed ID: 23612534
[TBL] [Abstract][Full Text] [Related]
65. Self-reported exercise and quality of life in young type 1 diabetic subjects.
Zoppini G; Carlini M; Muggeo M
Diabetes Nutr Metab; 2003 Feb; 16(1):77-80. PubMed ID: 12848309
[TBL] [Abstract][Full Text] [Related]
66. Youth Temperament Moderates Associations Between Parental Involvement and Pediatric Type 1 Diabetes Treatment Outcome.
Yeo AJ; Halpern LF; Lin B; Riddick L; Sima D; Wohlfahrt KM; Jones N
J Pediatr Psychol; 2022 Jul; 47(7):795-803. PubMed ID: 35278071
[TBL] [Abstract][Full Text] [Related]
67. Relationship between the cost of illness and quality of life among adolescents with type 1 diabetes-a mixed method study.
Chakrashali SB; Madhu B; Sree MM; Chaithra M; Sahana KS; Nagendra K
Sci Rep; 2024 Jun; 14(1):13403. PubMed ID: 38862532
[TBL] [Abstract][Full Text] [Related]
68. ADHD should be considered in adolescents with type 1 diabetes and poor metabolic control.
Nylander C; Fernell E
Diabetologia; 2021 Aug; 64(8):1897-1898. PubMed ID: 34109442
[No Abstract] [Full Text] [Related]
69. Quality of life among schoolchildren with type 1 diabetes mellitus and the satisfaction of their guardians towards school health care in Saudi Arabia.
Alfaleh A; Alkattan A; Alzaher A; Alhabib D; Alshatri A; Alnamshan A; Almalki O; Almutairi L; Khairat M; Sagor K; Alabdulkareem K; Ibrahim M
Diabetes Res Clin Pract; 2023 Oct; 204():110901. PubMed ID: 37699476
[TBL] [Abstract][Full Text] [Related]
70. Illness representations among adolescents with attention deficit hyperactivity disorder: associations with quality of life, coping, and treatment adherence.
Wong IYT; Hawes DJ; Dar-Nimrod I
Heliyon; 2019 Oct; 5(10):e02705. PubMed ID: 31687524
[TBL] [Abstract][Full Text] [Related]
71. Associated factors with depression and sleep quality in T1DM patients: a cross-sectional descriptive study.
Cho MK; Kim MY
BMC Psychiatry; 2023 Jan; 23(1):18. PubMed ID: 36624402
[TBL] [Abstract][Full Text] [Related]
72. How can we improve the management of individuals with attention deficit hyperactivity disorders and co-occurring cardiometabolic disease?
Larsson H
Expert Rev Cardiovasc Ther; 2023; 21(11):725-728. PubMed ID: 37925740
[No Abstract] [Full Text] [Related]
73. Understanding antagonism and synergism: A qualitative assessment of weight management in youth with Type 1 diabetes mellitus.
Kahkoska AR; Watts ME; Driscoll KA; Bishop FK; Mihas P; Thomas J; Law JR; Jain N; Mayer-Davis EJ
Obes Med; 2018 Mar; 9():21-31. PubMed ID: 29984330
[TBL] [Abstract][Full Text] [Related]
74. Effects of therapeutic patient education program on glycemic control and quality of life among children and adolescents with type 1 diabetes mellitus in Fez city, Morocco.
Ait-Taleb Lahsen H; Ragala MEA; El Abed H; Zarrouq B; Halim K
Perspect Clin Res; 2024; 15(1):24-30. PubMed ID: 38282632
[TBL] [Abstract][Full Text] [Related]
75. Clinical and Socio-Demographic Variables Associated with the Diagnosis of Long COVID Syndrome in Youth: A Population-Based Study.
Merzon E; Weiss M; Krone B; Cohen S; Ilani G; Vinker S; Cohen-Golan A; Green I; Israel A; Schneider T; Ashkenazi S; Weizman A; Manor I
Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627530
[TBL] [Abstract][Full Text] [Related]
76. The Willingness to Participate in Pediatric Type 1 Diabetes Studies.
Heinke S; Hommel A; Loff A; Berner R; Bonifacio E
Dtsch Arztebl Int; 2022 Jul; 119(27-28):488-489. PubMed ID: 36342093
[No Abstract] [Full Text] [Related]
77. Antivirals in the treatment of new-onset T1DM.
Greenhill C
Nat Rev Endocrinol; 2024 Jan; 20(1):2. PubMed ID: 37884739
[No Abstract] [Full Text] [Related]
78. An "out of the box" approach for prevention of ketoacidosis in youth with poorly controlled type 1 diabetes: combined use of insulin pump and long-acting insulin.
Barash G; Lerman L; Ben-Ari T; Abiri S; Landau Z; Ben Ami M; Brener A; Lebenthal Y; Pinhas-Hamiel O; Mazor-Aronovitch K; Haim A; Yeshayahu Y; De Vries L; Rachmiel M
Acta Diabetol; 2024 May; ():. PubMed ID: 38762619
[TBL] [Abstract][Full Text] [Related]
79. Serum levels of glucose, thyroid stimulating hormone, and free thyroxine in boys diagnosed with attention deficit hyperactivity disorder: a cross-sectional pilot study.
Lukovac T; Hil OA; Popović M; Savić T; Pavlović AM; Pavlović D
BMC Neurol; 2024 Feb; 24(1):76. PubMed ID: 38408935
[TBL] [Abstract][Full Text] [Related]
80. Lisdexamphetamine versus methylphenidate for paediatric patients with attention-deficit hyperactivity disorder and type 1 diabetes (LAMAinDiab): protocol for a multicentre, randomised cross-over clinical trial in an outpatient telemedicine-supported setting.
Michalak A; Chrzanowski J; Kuśmierczyk-Kozieł H; Klejman E; Błaziak K; Mianowska B; Szadkowska A; Chobot AP; Jarosz-Chobot P; Myśliwiec M; Makowska I; Kalenik A; Zamarlik M; Wolańczyk T; Fendler W; Butwicka A
BMJ Open; 2023 Dec; 13(12):e078112. PubMed ID: 38086595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
